Medical Data Vision Co., Ltd.
TSE:3902.T
427 (JPY) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,906.958 | 6,419.026 | 6,104.599 | 5,672.3 | 4,579.731 | 4,026.576 | 3,577.612 | 3,225.842 | 2,632.39 | 2,413.786 | 1,950.737 | 1,530.432 |
| Cost of Revenue
| 1,575.573 | 1,388.024 | 1,074.564 | 1,028.541 | 697.298 | 662.202 | 797.712 | 619.659 | 458.068 | 516.381 | 384.915 | 288.344 |
| Gross Profit
| 4,331.385 | 5,031.002 | 5,030.035 | 4,643.759 | 3,882.433 | 3,364.374 | 2,779.9 | 2,606.183 | 2,174.322 | 1,897.405 | 1,565.822 | 1,242.088 |
| Gross Profit Ratio
| 0.733 | 0.784 | 0.824 | 0.819 | 0.848 | 0.836 | 0.777 | 0.808 | 0.826 | 0.786 | 0.803 | 0.812 |
| Reseach & Development Expenses
| 0 | 68 | 332.985 | 316.638 | 113.076 | 21.677 | 0.955 | 6.262 | 16.279 | 6.154 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4,327.62 | 3,191.906 | 2,938.996 | 2,732.902 | 2,622.961 | 2,533.088 | 2,427.325 | 2,030.836 | 1,727.096 | 1,568.338 | 0 | 0 |
| Other Expenses
| 0 | 0.175 | 3,271.981 | 3,049.54 | 2,736.037 | 2,554.765 | -0.002 | 0.238 | -12.756 | 0.131 | -11.776 | 0.748 |
| Operating Expenses
| 4,327.62 | 3,260.081 | 3,271.981 | 3,049.54 | 2,736.037 | 2,554.765 | 2,428.28 | 2,037.098 | 1,743.375 | 1,614.912 | 1,305.233 | 1,032.35 |
| Operating Income
| 3.765 | 1,770.921 | 1,758.053 | 1,594.218 | 1,146.395 | 809.608 | 351.619 | 569.085 | 430.946 | 282.493 | 260.587 | 209.738 |
| Operating Income Ratio
| 0.001 | 0.276 | 0.288 | 0.281 | 0.25 | 0.201 | 0.098 | 0.176 | 0.164 | 0.117 | 0.134 | 0.137 |
| Total Other Income Expenses Net
| -731.073 | -202.999 | -331.47 | -2.322 | -69.8 | -151.711 | -36.634 | -21.777 | -137.111 | -20.105 | -16.213 | -0.308 |
| Income Before Tax
| -727.308 | 1,567.922 | 1,426.583 | 1,591.896 | 1,076.595 | 657.897 | 314.985 | 547.308 | 293.835 | 262.388 | 244.374 | 209.43 |
| Income Before Tax Ratio
| -0.123 | 0.244 | 0.234 | 0.281 | 0.235 | 0.163 | 0.088 | 0.17 | 0.112 | 0.109 | 0.125 | 0.137 |
| Income Tax Expense
| 76.168 | 613.624 | 569.516 | 491.858 | 374.082 | 112.248 | 253.586 | 192.708 | 115.626 | 98.377 | 108.912 | 4.504 |
| Net Income
| -791.17 | 979.125 | 870.509 | 1,087.267 | 700.22 | 554.315 | 69.47 | 354.599 | 178.209 | 164.01 | 135.461 | 204.925 |
| Net Income Ratio
| -0.134 | 0.153 | 0.143 | 0.192 | 0.153 | 0.138 | 0.019 | 0.11 | 0.068 | 0.068 | 0.069 | 0.134 |
| EPS
| -20.73 | 25.63 | 22.77 | 27.74 | 17.72 | 13.85 | 1.74 | 8.86 | 4.67 | 4.42 | 4.51 | 7.08 |
| EPS Diluted
| -20.73 | 25.63 | 22.76 | 27.74 | 17.72 | 13.85 | 1.74 | 8.86 | 4.47 | 4.19 | 4.08 | 7.08 |
| EBITDA
| 130 | 1,872 | 1,908.047 | 1,727.449 | 1,235.394 | 838.811 | 484.91 | 682.488 | 390.377 | 357.148 | 317.387 | 265.042 |
| EBITDA Ratio
| 0.022 | 0.292 | 0.313 | 0.305 | 0.27 | 0.208 | 0.136 | 0.212 | 0.148 | 0.148 | 0.163 | 0.173 |